Berlin’s Apheris and Ginkgo bring pharma giants together to train AI on 10,000 antibodies

Ginkgo Datapoints and Berlin-based Apheris today announced that the Antibody Developability Consortium has kicked off with its founding members. The Consortium is a new industry collaboration designed to help pharmaceutical and biotech companies predict manufacturability and developability risks earlier by building the field’s largest standardised antibody developability dataset. Apheris powers the largest federated data networks in drug discovery, used by leading pharmaceutical and biotech comp